Becton, Dickinson and Company

NYSE:BDX Stock Report

Market Cap: US$67.9b

Becton Dickinson Management

Management criteria checks 3/4

Becton Dickinson's CEO is Tom Polen, appointed in Apr 2017, has a tenure of 4.25 years. total yearly compensation is $17.31M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.02% of the company’s shares, worth $13.85M. The average tenure of the management team and the board of directors is 2.4 years and 6.5 years respectively.

Key information

Tom Polen

Chief executive officer

US$17.3m

Total compensation

CEO salary percentage7.6%
CEO tenure7yrs
CEO ownership0.02%
Management average tenure2.4yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30
Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12
Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05
With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22
Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Mar 20
Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Mar 05
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use

Feb 21

Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test

Feb 08

Becton, Dickinson Q1 2023 Earnings Preview

Feb 01

Becton, Dickinson declares $0.91 dividend

Jan 24

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Jan 09
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod

Jan 09

Becton, Dickinson: A Quality Defensive Pick For 2023

Dec 20

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Dec 01
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91

Nov 13
Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91

Becton, Dickinson Q4 2022 Earnings Preview

Nov 09

Becton, Dickinson, Biocorp team up for traceability of injectable drugs

Oct 18

Becton, Dickinson: Buy In Now While You Can

Oct 12

Does Becton Dickinson (NYSE:BDX) Have A Healthy Balance Sheet?

Oct 05
Does Becton Dickinson (NYSE:BDX) Have A Healthy Balance Sheet?

BD, Certest Biotec launch monkeypox test

Sep 26

Becton, Dickinson launches next-gen prefillable vaccine syringe BD Effivax

Sep 13

CEO Compensation Analysis

How has Tom Polen's remuneration changed compared to Becton Dickinson's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

US$1b

Sep 30 2023US$17mUS$1m

US$1b

Jun 30 2023n/an/a

US$2b

Mar 31 2023n/an/a

US$2b

Dec 31 2022n/an/a

US$1b

Sep 30 2022US$17mUS$1m

US$2b

Jun 30 2022n/an/a

US$1b

Mar 31 2022n/an/a

US$1b

Dec 31 2021n/an/a

US$1b

Sep 30 2021US$14mUS$1m

US$2b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

US$1b

Dec 31 2020n/an/a

US$2b

Sep 30 2020US$12mUS$952k

US$245m

Jun 30 2020n/an/a

US$786m

Mar 31 2020n/an/a

US$923m

Dec 31 2019n/an/a

US$760m

Sep 30 2019US$6mUS$900k

US$1b

Jun 30 2019n/an/a

US$784m

Mar 31 2019n/an/a

US$926m

Dec 31 2018n/an/a

US$894m

Sep 30 2018US$6mUS$850k

US$159m

Jun 30 2018n/an/a

US$621m

Mar 31 2018n/an/a

-US$99m

Dec 31 2017n/an/a

US$294m

Sep 30 2017US$4mUS$761k

US$1b

Compensation vs Market: Tom's total compensation ($USD17.31M) is above average for companies of similar size in the US market ($USD12.85M).

Compensation vs Earnings: Tom's compensation has been consistent with company performance over the past year.


CEO

Tom Polen (50 yo)

7yrs

Tenure

US$17,309,938

Compensation

Mr. Thomas E. Polen, Jr., also known as Tom, serves as Chief Executive Officer and Director at Becton, Dickinson and Company since January 28, 2020. Mr. Polen has been Director at Walgreens Boots Alliance,...


Leadership Team

NamePositionTenureCompensationOwnership
Thomas Polen
President7yrsUS$17.31m0.020%
$ 13.9m
Christopher DelOrefice
Executive VP & CFO2.6yrsUS$5.21m0.0014%
$ 964.8k
Shana Neal
Executive VP & Chief People Officer2yrsUS$5.89m0.0057%
$ 3.9m
David Hickey
Executive VP & President of Life Sciences Segment3.3yrsUS$3.35m0.0043%
$ 2.9m
Michael Garrison
Executive VP & President of Medical segment1.6yrsUS$3.65m0.0025%
$ 1.7m
Thomas Spoerel
Senior VP4.5yrsno data0.00083%
$ 563.9k
Elizabeth McCombs
Executive VP & Chief Technology Officer3yrsno datano data
Joseph Smith
Senior VP2.4yrsno datano data
Denise Fleming
Executive VP of Technology & Global Services and Chief Information Officer2.3yrsno datano data
Greg Rodetis
Head of Investor Relationsless than a yearno datano data
Michelle Quinn
Executive VP & General Counsel1.2yrsno data0.0017%
$ 1.2m
Claudia Curtis
Senior VPno datano datano data

2.4yrs

Average Tenure

53yo

Average Age

Experienced Management: BDX's management team is considered experienced (2.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Polen
President4.3yrsUS$17.31m0.020%
$ 13.9m
Joseph Smith
Senior VP2.4yrsno datano data
John DeFord
Co-Chair of Scientific Advisory Board2.9yrsno datano data
Robert Eckert
Independent Director7.6yrsUS$362.77k0.0028%
$ 1.9m
Timothy Ring
Independent Director7.3yrsUS$332.78k0.020%
$ 13.9m
Jeffrey Henderson
Independent Director5.7yrsUS$357.78k0.0019%
$ 1.3m
Christopher Ian Jones
Independent Director13.8yrsUS$362.78k0.0074%
$ 5.0m
Bertram Scott
Lead Independent Director21.6yrsUS$372.78k0.012%
$ 8.3m
Catherine Burzik
Independent Director11.3yrsUS$348.58k0.0046%
$ 3.1m
William Brown
Independent Director2.2yrsUS$332.78k0.00087%
$ 591.1k
Claire Fraser-Liggett
Member of Scientific Advisory Board & Independent Director17.4yrsUS$340.15k0.0079%
$ 5.3m
Carrie Byington
Independent Director2.5yrsUS$337.78k0.00099%
$ 672.6k

6.5yrs

Average Tenure

61yo

Average Age

Experienced Board: BDX's board of directors are considered experienced (6.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.